CardioDynamics

The company’s BioZ ICG systems are FDA-cleared and commercially available. They are used in physician offices and outpatient clinics to noninvasively assess hemodynamics for heart failure, hypertension, and related cardiovascular conditions. Over one million patient applications are performed annually with widespread adoption in U.S. cardiology offices and heart failure clinics. Clinical studies have demonstrated utility in improving diagnosis and management of cardiovascular disease by providing real-time hemodynamic data without invasive procedures. The technology has been validated through academic collaborations and featured by leading organizations such as the American College of Cardiology.